Högfeldt Therese, Jaing Crystal, Loughlin Kevin Mc, Thissen James, Gardner Shea, Bahnassy Abeer A, Gharizadeh Baback, Lundahl Joachim, Österborg Anders, Porwit Anna, Zekri Abdel-Rahman N, Khaled Hussein M, Mellstedt Håkan, Moshfegh Ali
Department of Oncology and Pathology, Karolinska Institute, 171 77 Stockholm, Sweden.
Chemistry, Materials, Earth and Life Sciences, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.
Oncol Lett. 2016 Oct;12(4):2782-2788. doi: 10.3892/ol.2016.5012. Epub 2016 Aug 16.
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.
弥漫性大B细胞淋巴瘤(DLBCL)是成人非霍奇金淋巴瘤(NHL)最常见的类型,约占全球新诊断淋巴瘤的30%-40%。环境因素,如病毒和细菌,可能通过慢性炎症和癌基因整合促进癌症发展,此前已在宫颈癌、肝细胞癌、胃癌和淋巴增殖性疾病中得到证实。在本研究中,对活化B细胞样(ABC)DLBCL患者的淋巴瘤组织中的微生物因子进行了分析。本研究比较了来自地理区域不同、病毒和其他微生物因子流行率存在差异的两组患者。患者群体分别来自瑞典(低地方性传染病地区)和埃及(高地方性传染病地区)。比较瑞典和埃及患者时,发现淋巴瘤组织中几种病毒存在差异表达。在瑞典和埃及患者中均检测到JC多瘤病毒(JCV),独特的是,仅在埃及淋巴瘤患者中检测到完整的乙型肝炎病毒(HBV)基因组。在瑞典或埃及的对照淋巴组织中均未检测到这些病毒。总体而言,38%的埃及患者血清中检测到HBV表面抗原(HBsAgs);然而,在任何瑞典患者中均未发现HBsAgs。与一般埃及人群相比,ABC DLBCL埃及患者血清HBsAgs的百分比显著升高(P<0.05)。本研究可能支持一种观点,即包括JCV和HBV在内的病毒因子可能参与高传染病地区DLBCL的肿瘤发生。